Physician

Matthew Joseph Roller, MD

According to 2025 Medicare claims, Matthew Roller, MD (NPI: 1033283379) practices neurology in the Grand Forks, ND-MN market, with the plurality of this provider's patient population coming from Grand Forks, ND. This provider's primary affiliated billing organization is ROLLER NEUROLOGY (NPI: 1780265009; TIN: 862188879) and primary practice location at 58201-2832. Roller is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), CVS ACO (ACO ID: A5407), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Roller's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 784 traditional Medicare patients, billed 26,532 HCPCS/CPT codes, and received $337,287 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,899 prescription claims across 633 beneficiaries totaling $1,249,819 in drug costs, led by Vumerity (Diroximel Fumarate). DME data shows 217 claims. Open Payments data shows 2 records totaling $59. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $84,448 to $337,287. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $18,853 and ending at $34,428.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$169K$337K2015 Medicare payment: $84,448 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $92,606 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $96,456 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $108,650 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $119,706 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $103,454 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $155,910 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $273,754 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $313,604 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $337,287 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158123,915$84,448
20168224,811$92,606
20178127,303$96,456
20188256,184$108,650
20198355,498$119,706
20208026,190$103,454
202172010,863$155,910
202273122,320$273,754
202376321,943$313,604
202478426,532$337,287

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.2M$2.3M2015 Drug cost: $1,683,770 (USD; Tot_Drug_Cst)2016 Drug cost: $1,574,704 (USD; Tot_Drug_Cst)2017 Drug cost: $2,027,281 (USD; Tot_Drug_Cst)2018 Drug cost: $2,011,243 (USD; Tot_Drug_Cst)2019 Drug cost: $2,302,968 (USD; Tot_Drug_Cst)2020 Drug cost: $2,029,771 (USD; Tot_Drug_Cst)2021 Drug cost: $2,073,830 (USD; Tot_Drug_Cst)2022 Drug cost: $1,519,549 (USD; Tot_Drug_Cst)2023 Drug cost: $1,643,934 (USD; Tot_Drug_Cst)2024 Drug cost: $1,249,819 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155774,809$1,683,770
20165494,621$1,574,704
20175836,540$2,027,281
20185966,229$2,011,243
20195956,458$2,302,968
20205886,315$2,029,771
20215675,781$2,073,830
20224764,723$1,519,549
20235695,256$1,643,934
20246335,899$1,249,819

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.1K$6.3K2015 Medicare payment: $878 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $374 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $3,757 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $6,272 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R26$878
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R12$374
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20231192$3,757
202413217$6,272

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more180263$79
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more236312$61
99238Hospital discharge day management, 30 minutes or less157163$59
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes2761,586$58
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's251389$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VumerityDiroximel Fumarate32960$271,881
GilenyaFingolimod Hcl12360$121,836
Avonex Pen (4 Pack)Interferon Beta-1a14392$115,110
Dimethyl FumarateDimethyl Fumarate411,410$71,023
Aimovig AutoinjectorErenumab-Aooe862,652$68,485

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R30$2,354
K0001Standard wheelchairYN/R59$1,256
E1392Portable oxygen concentrator, rentalYN/R30$1,129
E0143Walker, folding, wheeled, adjustable or fixed heightN1313$706
E0431Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubingYN/R20$333

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$59Eisai Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew Joseph Roller, MD?

Tedicare shows public-source Medicare data for Matthew Joseph Roller, MD (NPI 1033283379), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Joseph Roller, MD have ACO affiliation data?

Matthew Joseph Roller, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), CVS ACO (MSSP, ACO ID A5407), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Matthew Joseph Roller, MD?

Matthew Joseph Roller, MD is linked to ROLLER NEUROLOGY (billing NPI 1780265009) in the available physician profile data.

Does Matthew Joseph Roller, MD have Open Payments data?

Matthew Joseph Roller, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.